Douglas F. Beach, MD
Clinical Associate Professor of Medicine (Hematology-Oncology)
Department: Medicine
Contact information
Penn Hematology/Oncology
230 W. Washington Square, 2nd Floor
Philadelphia, PA 19106
230 W. Washington Square, 2nd Floor
Philadelphia, PA 19106
Office: 215-829-7256
Fax: 215-829-6104
Fax: 215-829-6104
Education:
BA
Rutgers University, 2001.
MD
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 2006.
Permanent linkBA
Rutgers University, 2001.
MD
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 2006.
Description of Clinical Expertise
Breast/Ovarian Cancer Screening; Leukemia/Lymphoma; CLL; Benign Heme; Clotting disorders; Prostate Cancer; Lung Cancer; indolent NHLSelected Publications
John G. Gribben, MD DSc, FRCP, FRCPath, FMedSci, Wojciech Jurczak, MD PhD, Ryan W. Jacobs, MD, Sebastian Grosicki, MD PhD, Krzysztof Giannopoulos, MD PhD, Tomasz Wrobel, MDPhD, Syed F. Zafar, MD, Jennifer L. Cultrera, MD, Suman Kambhampati, MD, Alexey Danilov, MD, John M. Burke, MD, Jerome Goldschmidt, MD, Douglas F. Beach, MD, Scott F. Huntington, MD MPH, Javier Pinilla Ibarz, MD PhD, Jeff P Sharman, MD, Tanya Siddiqi, MD, Danielle M. Brander, MD, John M. Pagel, MDPhD, Kathryn S. Kolibaba, MD, Monika Dlugosz-Danecka, MD PhD, Nilanjan Ghosh, MD PhD, Peter Sportelli, BS, Hari P. Miskin, MSc, Owen A. O'Connor, MD PhD, Michael S. Weiss, Ian W. Flinn, MD PhD: Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study. Blood (2020) 136 (Supplement 1): 37–39 136: 37–39, November 2020 Notes: "Virtual Presentation"Riley SV, Beach DF. : Making Progress: Impact of Diabetes on Metastatic Colon Cancer Disease Progression. J. Neoplasm. 5(1:1), 2020.
Mato, A. R.,Roeker, L. E.,Allan, J. N.,Pagel, J. M.,Brander, D. M.,Hill, B. T.,Cheson, B. D.,Furman, R. R.,Lamanna, N.,Tam, C. S.,Handunnetti, S.,Jacobs, R.,Lansigan, F.,Bhavsar, E.,Barr, P. M.,Shadman, M.,Skarbnik, A. P.,Goy, A.,Beach, D. F.,Svoboda, J.,Pu, J. J.,Sehgal, A. R.,Zent, C. S.,Tuncer, H. H.,Schuster, S. J.,Pickens, P. V.,Shah, N. N.,Rhodes, J.,Ujjani, C. S.,Nabhan, C. : Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial. Am J Hematol 93(11): 1394-1401, Nov 2018.
Danielle M. Brander, MD, Joanna Rhodes, MD, John M. Pagel, MD PhD, Chadi Nabhan, MD MBA, FACP, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ryan Jacobs, MD, Brian T. Hill, MD PhD, Nicole Lamanna, MD, Frederick Lansigan, MD, Mazyar Shadman, MD, Chaitra S. Ujjani, MD, Alan P Skarbnik, MD, Bruce D. Cheson, MD, Jeffrey J. Pu, MD PhD, Alison R. Sehgal, MD, Paul M. Barr, MD, John N. Allan, MD, Douglas F. Beach, MD, Bhavisha Patel, MD, Peter V. Pickens, MD, Sunita Dwivedy Nasta, MD, Kaitlin Kennard, RN, BSN, Hande H. Tuncer, MD, Brittany Koch, MPH, Richard R. Furman, MD, Anthony R. Mato, MD: Applicability of the Chronic Lymphocytic Leukemia (CLL)-IPI on Patients Treated with Front-Line Ibrutinib in the Real World: The Case for New Prognostic Models. Blood 130 (Supplement 1), December 2017.
Anthony R. Mato, MD, John N. Allan, MD, John M. Pagel, MD PhD, Danielle M. Brander, MD, Brian T. Hill, MD PhD, Bruce D. Cheson, MD, Richard R. Furman, MD, Nicole Lamanna, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ryan Jacobs, MD, Frederick Lansigan, MD, Paul M. Barr, MD, Mazyar Shadman, MD, Alan P Skarbnik, MD, Douglas F. Beach, MD, Jeffrey J. Pu, MD PhD, Alison R. Sehgal, MD, Allison M. Winter, MD, Clive S Zent, MD, Hande H. Tuncer, MD, Arun K Singavi, MD, Stephen J. Schuster, MD, Peter V. Pickens, MD, Nirav N Shah, MD, Annalynn Williams, MS, Christina Howlett, PharmD, BCOP, Hanna Weissbrot, BS, Naveed Ali, MD, Bhavisha Patel, MD, Krista Isaac, DO, MS, Joanna Rhodes, MD, Mitchell E. Hughes, PharmD, BCPS, BCOP, Sirin Khajavian, MD, Elizabeth T Chatburn, BS, Andrea Sitlinger, MD, Eve Tranchito, BS, Erica Bharat Bhavsar, BS, Neil Bailey, MS, Timothy F. Burns, MD, Melissa Yacur, MD, Mansi Malhotra, BS, Sasanka Handunnetti, MD, Kaitlin Kennard, RN, BSN, Chadi Nabhan, MD MBA, FACP, Chaitra S. Ujjani, MD: Front-Line Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in the Real World: Responses, Toxicity, Outcomes and Subsequent Therapies. Blood 130 (Supplement 1), December 2017.
Oren O, Oren M, Beach D : On the generalizability of prostate cancer studies: why race matters. Ann Oncol 27(12): 2146-2148, Aug 29 2016.
Grant S, Meykler S, Beach D : Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma. J Community Support Oncol 12(11): 415-417, November 2014.
Beach DF, Barnoski B, Patel V, Schwarting R, Strair R, Lachant N: Duplication of chromosome 1 [dup(1)(q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML. Cancer Genetics 205(12): 665-668, December 2012 Notes: Epub 2012 Nov 16.
Beach DF, Klump W, Haddad G, Reid LM, Schwarting R, Hageboutros A. : Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland. Medical Oncology 29(3): 1405-1408, September 2012 Notes: Epub 2011 June 5.
Beach D, Somer R: Metastatic Renal Cell Carcinoma to the Phalanx. Urology 79(5): e77, May 2012 Notes: Epub 2011 Nov 23.